Loading...
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS.
Gollins, S West, N Sebag-Montefiore, D Susnerwala, S Falk, S Brown, N Saunders, Mark P Quirke, P Ray, R Parsons, P
Gollins, S
West, N
Sebag-Montefiore, D
Susnerwala, S
Falk, S
Brown, N
Saunders, Mark P
Quirke, P
Ray, R
Parsons, P
Citations
Altmetric:
Abstract
Neoadjuvant chemotherapy (NAC) allows earlier treatment of rectal cancer micro-metastases but is not standard of care. There are currently no biomarkers predicting long-term progression-free survival (PFS) benefit from NAC.
Description
Date
2018-08-15
Publisher
Collections
Files
Keywords
Type
Article
Citation
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. 2018, Br J Cancer